Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Rivastigmine 13.3mg/24h transdermal patch (Voleze®)
Rivastigmine 13.3mg/24h transdermal patch (Voleze®)
Shared care guideline available
- Traffic Light
Amber (SCG)
- BNF
- Licensed Indicators
Mild to moderate severe alzhemiers disease
- Reference
APC Jan 15
- Criteria
- Provisional
No
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik